Effect of timing, technique and molecular features on brain control with local therapies in oncogene-driven lung cancer

BACKGROUND: The improved efficacy of tyrosine kinase inhibitors (TKI) mandates reappraisal of local therapy (LT) for brain metastases (BM) of oncogene-driven non-small-cell lung cancer (NSCLC). PATIENTS AND METHODS: This study included all epidermal growth factor receptor-mutated (EGFR(+), n = 108)...

Descripción completa

Detalles Bibliográficos
Autores principales: El Shafie, R.A., Seidensaal, K., Bozorgmehr, F., Kazdal, D., Eichkorn, T., Elshiaty, M., Weber, D., Allgäuer, M., König, L., Lang, K., Forster, T., Arians, N., Rieken, S., Heussel, C.-P., Herth, F.J., Thomas, M., Stenzinger, A., Debus, J., Christopoulos, P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8182387/
https://www.ncbi.nlm.nih.gov/pubmed/34090172
http://dx.doi.org/10.1016/j.esmoop.2021.100161

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8182387/
https://www.ncbi.nlm.nih.gov/pubmed/34090172
http://dx.doi.org/10.1016/j.esmoop.2021.100161

Ejemplares similares